In particular, while in an ovalbumin (OVA)-expressing tumor model, the treatment with an OX40 agonist reduced the differentiation of T cells into effectors aged mice compared to younger mice [246], other studies have revealed that T cells transferred into aged mice exhibit heightened OX40 signaling and activation [247]. The gene discussed is TNFRSF4; the disease is neoplasm.